Healthcare Roundup – Late-stage study of Emergent Bio’s COVID-19 plasma, Lilly’s baricitinib shows incremental benefit Life Science
Healthcare Roundup – Regeneron +2.3% after Trump praises drug, Aprea on go with early-stage study with APR-548 Life Science
Healthcare Roundup – Crispr Therapeutics started with Buy at BofA, Zai Lab commences late-stage study of retifanlimab Life Science
Healthcare Roundup – Trump taking Regeneron antibody cocktail, Study of AstraZeneca COVID-19 vaccine resumes in Japan Life Science
Healthcare Roundup – Amazon says nearly 20,000 workers got COVID-19, FDA OKs emergency use of Beckman test Life Science
Healthcare Roundup – Moderna won’t seek FDA emergency use nod before November 25, AstraZeneca/Oxford COVID-19 vaccine nabs accelerated review in Europe Life Science
Healthcare Roundup – Aptorum Group raises $9M in public offering, Pfizer inks deal with CStone Life Science
Healthcare Roundup – Analysts move to sidelines on Inovio on delay in pivotal COVID-19 vaccine study, JD.com’s Health-Care Business to go public in Hong Kong Life Science
AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside Life Science
Healthcare Roundup – J&J COVID-19 vaccine sees strong immune response in early trial, Gilead and Galapagos’ filgotinib OK’d in Europe for rheumatoid arthritis Life Science
Healthcare Roundup – White House may overrule tightening of FDA vaccine rules, Novavax initiates pivotal study of COVID-19 vaccine candidate Life Science
Healthcare Roundup – NeuroRx requests emergency use of RLF-100 in COVID-19, AstraZeneca’s late-stage U.S. study of COVID-19 vaccine still on hold Life Science
Healthcare Roundup – Stricter FDA standards make COVID-19 vaccine approval unlikely before election day, Adial commence sale of COVID-19 test kits Life Science
